We are leveraging the power of the dark genome to develop precise and potent RNA therapies for reprogramming disease driving cell-states.
Accelerating the development of the next-generation of dark genome targets and therapeutics for underserved rare and chronic diseases.
Dark Genome derived regulatory RNAs
Diseased tissues & cells identified with proprietary tools & methods
Targeting lncRNAs processes & integration of environmental signals when modulating the epigenome
Emerging RNA-targeting modalities, such as modified antisense oligonucleotides (ASOs), to target and inhibit proprietary lncRNAs to prevent and reverse disease
A short list of our supporters and awards